Qualia Studies

Qualia Senolytic Placebo-Controlled Clinical Study Results

Qualia Senolytic Placebo-Controlled Clinical Study Results

A double-blind, placebo-controlled clinical trial of Qualia Senolytic showed a statistically significant reduction in total scores of issues related to joint health and performance, which includes Joint Discomfort, Physical Function, and Joint Stiffness. 

Read More

Qualia NAD+ Placebo-Controlled Clinical Study Results

Qualia NAD+ Placebo-Controlled Clinical Study Results

Read the exciting results of our double-blind, placebo-controlled clinical trial of Qualia NAD+.

Read More

Qualia Synbiotic Beta Study

Qualia Synbiotic Beta Study

Qualia Synbiotic Enhanced Healthy Digestive Performance in Just 15 Days. Thirty-six healthy adults completed the study. All participants reported occasional, mild-to-moderate digestive complaints before taking Qualia Synbiotic. Participants were given enough Qualia Synbiotic to take one serving per day for fifteen days per label recommendations.

Read More

Qualia Senolytic Beta Study

Qualia Senolytic Beta Study

During the development of Qualia Senolytic, Qualia put our newest healthy aging product to the test to find out how users would respond. 

Read More

Qualia Resilience Beta Study

Qualia Resilience Beta Study

During the development of Qualia Resilience, Qualia put our stress product to the test to find out how users would respond. Spoiler Alert: Results were really good.

Read More

Qualia Life Beta Study

Qualia Life Beta Study

In September-October 2018, a 3-week sample of Qualia Life (formerly called Eternus) was sent to volunteers. Volunteers were selected to include a mix of people who were and were not currently taking Qualia Mind. No information was given on what product was intended to do, ingredients contained in the product, or expected responses. Instructions were to take 8 capsules with breakfast 5 days a week, with 2 off days, for 3 weeks. All participants were asked to complete a survey questionnaire after 5 days, 2 weeks, and 3 weeks. Seventy-one persons completed the 3 weeks of supplementation and provided responses to the survey. 

Read More

Qualia Focus Beta Study

Qualia Focus Beta Study

Qualia Focus was formulated as a nootropic to support mental energy. When the brain has more resources that support mental energy, the demanding cognitive functions we need to do during the day—tasks that take mental effort—feel easier. 

Read More

Qualia Skin Beta Study

Qualia Skin Beta Study

This study aimed to assess whether Qualia Skin, by providing skin nourishment from within and supporting comprehensive skin health and healthy skin aging, would change participant satisfaction and self-ratings of aspects of the skin’s feel and appearance.

Read More

Qualia Mind Energy Shot Beta Study

Qualia Mind Energy Shot Beta Study

In April-May 2019, an unflavored and unsweetened 5-day sample of Qualia Mind Energy Shot was sent to members of our beta tester community. Here's how the data stacked up.

Read More

Qualia Vision Beta Study

Qualia Vision Beta Study

During the development of Qualia Vision, volunteers with high amounts of daily screen time agreed to take the product and give feedback about their experiences of screen time eye strain issues. Here are the survey results.

Read More

Qualia Senolytic Pilot Study - Impact on RAND SF-36 Scores Following Repeated Dosing

Qualia Senolytic Pilot Study - Impact on RAND SF-36 Scores Following Repeated Dosing

The 36-Item Short Form Survey Instrument (SF-36) was developed at RAND as part of the Medical Outcomes Study. It is one of the most widely used tools to assess health status and health-related quality of life.

Read More

Qualia NAD+ Beta Study

Qualia NAD+ Beta Study

During the development of Qualia NAD+ we put our newest product to the test to find out how users would respond. Here’s what we did, and how participants responded.

Read More

How Personalized Lifestyle Interventions Are Making a Meaningful Impact on Cognitive Decline

How Personalized Lifestyle Interventions Are Making a Meaningful Impact on Cognitive Decline

A new study provides hope as cognitive decline improved after six months of personalized lifestyle interventions, including Qualia Mind.

Read More

Qualia Life Pilot Study NAD+, NMN, & NR

Qualia Life Pilot Study NAD+, NMN, & NR

A small pilot study of Qualia Life—originally branded as Eternus—was conducted on 9 individuals in November-December 2019 as part of a larger research project by Longevity Diagnostics Research.

Read More

Qualia Life Agemeter® Pilot Study

Qualia Life Agemeter® Pilot Study

A small pilot study of Qualia Life—originally branded as Eternus—was conducted during the winter months of 2019-20. Functional testing was done using the AgeMeter® device and software.

Read More